The Pilot Study:Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes.
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 10 Jan 2019
At a glance
- Drugs Pramlintide (Primary) ; Insulin glargine
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 13 May 2009 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 20 Aug 2007 New trial record.